scholarly journals Pregabalin-Induced Remission in a 62-Year-Old Woman with a 20-Year History of Vulvodynia

2007 ◽  
Vol 12 (3) ◽  
pp. 212-214 ◽  
Author(s):  
Laurence Jerome

A case of a 62-year-old woman presenting with a 20-year history of vulvodynia previously unresponsive to medical treatment is described. The epidemiology, phenomenology and medical management of vulvodynia is reviewed. The case presentation illustrates the role of pregabalin in successful medical management of this chronic pain disorder, as well as the management of common psychiatric morbidities associated with this condition.

2000 ◽  
Vol 41 (3) ◽  
pp. 227-234 ◽  
Author(s):  
Jon Streltzer ◽  
Byron A. Eliashof ◽  
Amy E. Kline ◽  
Deborah Goebert

2013 ◽  
Vol 47 (1) ◽  
pp. 24-31 ◽  
Author(s):  
Ulrich Voderholzer ◽  
Caroline Schwartz ◽  
Nicola Thiel ◽  
Anne Katrin Kuelz ◽  
Armin Hartmann ◽  
...  

2013 ◽  
Vol 63 (4) ◽  
pp. 253-259 ◽  
Author(s):  
H. Hamer ◽  
R. Gandhi ◽  
S. Wong ◽  
N. N. Mahomed

2021 ◽  
Vol 12 ◽  
pp. 215013272110384
Author(s):  
Michael Boulis ◽  
Mary Boulis ◽  
Daniel Clauw

Fibromyalgia, a widespread chronic pain disorder, imposes a multitude of hardships on patients and their communities. Supplements, specifically magnesium supplements, have been widely used by fibromyalgia patients in an attempt to control their symptoms. The aim of this work is to investigate if the widespread use of magnesium in fibromyalgia is supported by evidence in the literature. This review provides a layout of the studies examining the correlation between body magnesium levels and fibromyalgia. Furthermore, it elaborates on the trials testing the effectiveness of magnesium in treating different clinical parameters of fibromyalgia.


Author(s):  
Emanuele Maria Giusti

Abstract Fibromyalgia is a chronic pain disorder with a multifaceted nature and its biological, psychological and social aspects are strongly interconnected. Therefore, the integration of the different health disciplines is strongly recommended for its care. There is a growing number of interventions based on this principle but each of them is heterogeneous with regards to how the included disciplines are integrated with each other. With this regards, multidisciplinary and interdisciplinary programs are distinguished. The former are organized in order to treat the various aspects of the syndrome using different perspectives and their various treatment components are usually provided separately by the different care providers. Conversely, interdisciplinary treatments are planned in order to foster a dialogue between the operators by providing a joint conduction of the treatment or scheduling plenary discussions about the cases. In the field of chronic pain, some authors are suggesting to move beyond these approaches and to plan transdisciplinary treatments, which would allow the professionals to move across their disciplinary boundaries. Although no examples of these interventions have been proposed for the treatment of fibromyalgia, there is a visible trend in the literature toward more holistic forms of care.


2015 ◽  
Vol 2 (4) ◽  
Author(s):  
Mohammad Kianbakht ◽  
Ghasem Ansarinia ◽  
Shiva Nematpour kapourchal

Object (s): the present research has considered the relationship between beliefs, perceptions of pain with intensity of chronic pain disorder. Methods: these fire fighters of the city of 4 research is known as sectional study. In such a study, Tehran was selected by cluster sampling. Data from the questionnaires, chronic pain, pain beliefs and formed perceptions, coping strategies and perfectionism were collected. Data is analyzed by the step by step method which is called regression analyses method. Results: there was positive significant relation between beliefs in continuous pain in the future, belief in self-blame, belief in pain stability at the present, belief in mysterious pain with the intensity of chronic pain disorder as well as, according to the multiple variable of regression analyses, the results has been showed that, the contribution of each pre-variable, self-blame  continuous pain separately is as follow; Mysterious pain; as well as the various intensity of pain disorder was , pain stability  explained too. Conclusion: Regard with result of this study, it is essential to create self-adaptive belief in the patients who suffer from chronic pain, so if we use the treatment of self-adaptive cognition along with other treatments to reduce pain, it can have more benefit to control and reduce the chronic pain among the firemen who suffer from it.


2018 ◽  
Vol 2 (3) ◽  
pp. e35-e63 ◽  
Author(s):  
David R Mack ◽  
Eric I Benchimol ◽  
Jeff Critch ◽  
Jennifer deBruyn ◽  
Frances Tse ◽  
...  

AbstractBackground & AimsWe aim to provide guidance for medical treatment of luminal Crohn’s disease in children.MethodsWe performed a systematic search of publication databases to identify studies of medical management of pediatric Crohn’s disease. Quality of evidence and strength of recommendations were rated according to the GRADE (Grading of Recommendation Assessment, Development, and Evaluation) approach. We developed statements through an iterative online platform and then finalized and voted on them.ResultsThe consensus includes 25 statements focused on medical treatment options. Consensus was not reached, and no recommendations were made, for 14 additional statements, largely due to lack of evidence. The group suggested corticosteroid therapies (including budesonide for mild to moderate disease). The group suggested exclusive enteral nutrition for induction therapy and biologic tumor necrosis factor antagonists for induction and maintenance therapy at diagnosis or at early stages of severe disease, and for patients failed by steroid and immunosuppressant induction therapies. The group recommended against the use of oral 5-aminosalicylate for induction or maintenance therapy in patients with moderate disease, and recommended against thiopurines for induction therapy, corticosteroids for maintenance therapy, and cannabis in any role. The group was unable to clearly define the role of concomitant immunosuppressants during initiation therapy with a biologic agent, although thiopurine combinations are not recommended for male patients. No consensus was reached on the role of aminosalicylates in treatment of patients with mild disease, antibiotics or vedolizumab for induction or maintenance therapy, or methotrexate for induction therapy. Patients in clinical remission who are receiving immunomodulators should be assessed for mucosal healing within 1 year of treatment initiation.ConclusionsEvidence-based medical treatment of Crohn’s disease in children is recommended, with thorough ongoing assessments to define treatment success.


2018 ◽  
Vol 9 ◽  
Author(s):  
Katrin Elisabeth Giel ◽  
Sarah Paganini ◽  
Irena Schank ◽  
Paul Enck ◽  
Stephan Zipfel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document